Latest Nephrology news and features
Latest Urology news and features
Download our free app for iOS or Android
Treatment of LUTS secondary to BPH has evolved from surgical therapy to medical monotherapy, and now combination therapy.
Given the frequency with which these lesions are found, urologists and nephrologists should be familiar with their evaluation.
March 01, 2013
Many but not all cohort studies examining the relationship between hyperuricemia and CKD outcomes suggest they may be intertwined.
Emerging data suggest that thyroid hormone deficiency may be associated with greater cardiovascular morbidity and mortality in this population.
In both nutritional and activated forms, vitamin D may have side effects that are as yet under-appreciated.
February 01, 2013
Obese individuals often are rejected as renal transplant candidates in large part because of their increased risk for surgical complications and adverse outcomes.
Urologists typically treat a renal cortical mass without biopsy, but this should be re-evaluated in the era of the incidental small renal cortical neoplasm.
Scientific speculation suggests that uremic toxins, viral mediators, and immune inhibition could play a role in malignant transformation.
It is hoped that selective screening, selective biopsy, and selective therapy will further decrease the morbidity associated with screening.
The routine incorporation of NMIBC clinical practice guidelines will reduce variation in care by closing the gap on inappropriate delivery, whether over- or underuse.
October 03, 2012
The complex disease requires regular follow up and assessment of the ongoing response to therapy.
With increased incidence of obesity—and higher caloric and salt intake—in the general population, resistant hypertension is more prevalent than ever.
Given the intimate anatomical and physiological relationship of the adrenals to the kidney, an understanding of adrenal disease is imperative for urologists and nephrologists alike.
The management of patients with high-risk prostate cancer represents one of the biggest challenges today, with little consensus on optimal treatment.
Clinicians need to keep abreast of the most current treatment options for NGB, which can result in improved patient outcomes and quality of life.
Despite recent advances in the treatment of hypertension, the majority of patients with chronic kidney disease (CKD) still remain above current blood pressure (BP) targets.
A case study involving a 58-year-old man with acute gout attacks and multiple comorbidities, including hypertension and hypercholesterolemia.
Approximately 30%-50% of SLE patients have clinically evident renal disease at presentation, but renal involvement occurs in up to 60% of patients overall.
Diagnostics and treatment options for NGB are continually advancing, and clinicians need to remain up-to-date to accurately assess and optimally manage patients
Pre-existing renal osteodystrophy at the time of transplantation, reduced renal function, and transplantation-specific therapies are the main contributing factors.
April 01, 2012
As you develop and grow a home HD program, not only will you have wonderful successes, but there will also be challenges and disappointments.
A case study involving a 65-year-old man with chronic kidney disease and acute attacks of pain, swelling, and erythema in the first metatarsophalangeal joint.
March 22, 2012
This is the title of a scheduled May 12 session at the National Kidney Foundation's 2012 Spring Clinical Meetings.
A case study examines the treatment of hyperuricemia and gout in a 57-year-old postmenopausal renal transplant recipient with intermittent gout attacks.
February 29, 2012
An impressive story of a dialysis survivor who watched his daughters grow and getting married, and had the joy of knowing several grandchildren.
Patients who undergo renal transplantation require complex care that involves a diligent, multidisciplinary approach.
Short-term outcomes from early institutional experiences have confirmed the safety and feasibility of RPN, even for anatomically complex tumors.
December 01, 2011
Gout is increasingly recognized in patients with chronic kidney disease, but the proper dosing regimen for traditional agents has not been well-studied in this patient group.
November 01, 2011
An overview of how CROWNWeb, CMS' Web-based end-stage renal disease (ESRD) data-collection system, has been updated with vaccination, hospitalization, and infection data to help CMS, the ESRD Networks, and dialysis facilities better analyze patient care efforts.
November 01, 2011
In determining prostate cancer treatment, physicians should discuss preferences, values, and expectations with patients, including life expectancy, adverse events, and costs
October 01, 2011
Therapeutic options for SIADH have been significantly enhanced with the introduction of specific vasopressin receptor antagonists
Solid evidence for a survival benefit from PSA screening for prostate cancer is lacking, but the practice is more widespread in the United States than in many European countries.
September 09, 2011
Four nephrologists weigh in about the substantive differences in dialysis implementation in this country and worldwide.
September 01, 2011
George Bakris, MD, spoke about various aspects of treating hypertension in patients with chronic kidney disease.
September 01, 2011
In select patients, use of intermittent therapy does not appear to negatively affect overall survival and is associated with fewer adverse events.
August 01, 2011
Etiology and treatment are clearly defined for infectious prostatic syndromes, but not for chronic pelvic pain syndrome.
July 27, 2011
Dr. D, 29, was the chief resident finishing up his final year of a surgical residency in a prestigious hospital. Life was golden for the young doctor. He had been a bright and talented student in medical school, and stood out during his residency.
July 01, 2011
The complex biological actions of vitamin D suggest its involvement in various pathologies. (This is the second of a two-part CME article.)
June 01, 2011
Research has shown that vitamin D deficiency has a role in the progressive loss of kidney function as well as increased mortality.
May 01, 2011
A history of prostate cancer has generally been a contraindication for testosterone therapy, but the clinical model may be changing.
April 18, 2011
Physicians' experiences as patients may cause them to reflect on the medical care they provide.
April 01, 2011
Following a renal biopsy diagnosis of IgA nephropathy, clinicians need to estimate prognosis and design an appropriate short- and long-term treatment strategy.
March 01, 2011
Recent advances in understanding genetic changes associated with kidney tumor formation have led to new pathologic classifications.
February 01, 2011
This article addresses the issues that must be understood to navigate the scenario posed by patients that have had a prior negative biopsy.
January 01, 2011
The management of chronic kidney disease-mineral bone disorder (CKD-MBD) is central to the care of patients with kidney disease. Key to these efforts is the availability of clinically accessible biomarkers that can help distinguish between a wide variety of bone and mineral disturbances related to kidney failure.
Endocrinologist William Rosner, MD, Professor of Medicine at Columbia University in New York, explains to Renal & Urology News what impending testosterone-testing standardization—and the current lack of it—means to urology practice and research.
Regulatory changes have enhanced clinicians' ability to recommend the modality, which offers long-term survival similar to that of hemodialysis.
October 11, 2010
Fed up with the frustrations of private practice, some urologists and nephrologists have chosen the life of an itinerant professional.
August 12, 2010
Vaccine for advanced castration-resistant prostate cancer prolongs life by a median of four months, but at an extremely high cost.
July 12, 2010
One practitioner's perceived good deed for a dying patient could be another's definition of homicide.
